Antonella Converso

The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents

P.H. Hutson, Eleftheria N. Finger, Brian C. Magliaro et al. · Neuropharmacology · 2011 · 139 citations

Life Sciences, Neuroscience, Pharmacology +16

Comparison of amine additives most effective in the new methyltrioxorhenium-catalyzed epoxidation process

Hans Adolfsson, Antonella Converso, K. Barry Sharpless · Tetrahedron Letters · 1999 · 123 citations

Natural Sciences, Chemical Engineering, Chemistry +13

Development of thioquinazolinones, allosteric Chk1 kinase inhibitors

Antonella Converso, Timothy J. Hartingh, R. M. Garbaccio et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 74 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 Attenuates a Scopolamine-Induced Deficit in a Novel Rodent Attention Task

Joshua D. Vardigan, Antonella Converso, Pete H. Hutson et al. · Journal of Neurogenetics · 2011 · 53 citations

Life Sciences, Neuroscience, Pharmacology +17

Studies toward the Synthesis of Azadirachtin, Part 2: Construction of Fully Functionalized ABCD Ring Frameworks and Unusual Intramolecular Reactions Induced by Close‐Proximity Effects

K. C. Nicolaou, Pradip K. Sasmal, Theocharis V. Koftis et al. · Angewandte Chemie International Edition · 2005 · 49 citations

Natural Sciences, Chemistry, Medicinal Chemistry +12